Prof Simonds comments on the results of the SERVE-HF trial and also discusses the different uses of ASV as therapy for complex sleep apnoea, central sleep apnoea, and opioid-induced sleep disordered breathing. She notes that significant findings have been made regarding the correct usage of ASV, but acknowledges that more work is required in this area.
This video was funded by Resmed.
